Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Staying informed about common mistakes and realistic expectations can help counteract the nocebo effect without leaving you uninformed
doi: 10.1186/s13052-022-01319-1 73 CrinASchiaffiniRCiampaliniPSperaSBeccariaLBenziFet al
Table 15: Lipid-Modifying Effects of Rosuvastatin 10 mg and 20 mg in Adult Patients with Primary Dysbetalipoproteinemia (Type III hyperlipoproteinemia) After Six Weeks by Median Percent Change (95% CI) from Baseline (N=32) Hypertriglyceridemia in Adults In a double-blind, placebo-controlled study in adult patients with baseline TG levels from 273 to 817 mg/dL, rosuvastatin given as a single daily dose (5 to 40 mg) over 6 weeks significantly reduced serum TG levels (see Table 16)
Structure-function investigations : Exploring how peptide modifications influence stability and exposure in research settings
US$ 22.38
US$ 23.21
US$ 25.68
US$ 22.71
US$ 28.58
